<?xml version="1.0"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
<channel>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
<description>BloggingStocks</description>
<image>
<url>http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif</url>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
</image>
<language>en-us</language>
<copyright>Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only.</copyright>
<generator>Blogsmith http://www.blogsmith.com/</generator><item><title><![CDATA[Elan Corp. always has the mind on its mind]]></title><link>http://www.bloggingstocks.com/2008/02/08/elan-corp-always-has-the-mind-on-its-mind/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2008/02/08/elan-corp-always-has-the-mind-on-its-mind/</guid><comments>http://www.bloggingstocks.com/2008/02/08/elan-corp-always-has-the-mind-on-its-mind/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/stocks-to-buy/" rel="tag">Stocks to Buy</a></p>The choppy/consolidating (or perhaps worse) market conditions sometimes give the impression that growth plays do not exist, but that is not the case, and one growth company worth reviewing is Elan Corp. Note: Elan is appropriate only for investors who can tolerate high-risk.<br /><br /><a href="http://finance.aol.com/quotes/elan-corporation-plc/eln/nys?tabs=quotesandnews">Elan Corp.</a> (NYSE: <a href="http://finance.aol.com/quotes/elan-corporation-plc/eln/nys?tabs=quotesandnews">ELN</a>) is a neuroscience-based technology company focused on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases and severe pain. <br /><br />Analysts sees 33-40% revenue growth for Elan in 2008 after likely 30-35% growth in 2007. <br /><br />Analysts also like Elan's ramping sales for drug Tysabri for multiple sclerosis and Crohn's disease; they are also hopeful about the company's Alzheimer drug, bapineuzmab, currently in trials. <p><a href="http://www.bloggingstocks.com/2008/02/08/elan-corp-always-has-the-mind-on-its-mind/" rel="bookmark">Continue reading <em>Elan Corp. always has the mind on its mind</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2008/02/08/elan-corp-always-has-the-mind-on-its-mind/">Elan Corp. always has the mind on its mind</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Fri, 08 Feb 2008 11:12:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2008/02/08/elan-corp-always-has-the-mind-on-its-mind/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/1109706/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2008/02/08/elan-corp-always-has-the-mind-on-its-mind/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>autoimmune diseases</category><category>biotech</category><category>Elan Corp.</category><category>ELN</category><category>health care</category><category>neurology</category><category>pharmaceuticals</category><dc:creator><![CDATA[Joseph Lazzaro]]></dc:creator><pubDate>Fri, 08 Feb 2008 11:12:00 EST</pubDate></item></channel></rss>
